Diseases of the Digestive System - Liver, Phase III

Safety, Tolerability, and Efficacy of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis (PRIMIS)

Volunteers
Health Professionals

What is the purpose of this trial?

The primary objective of this study is to evaluate whether cilofexor reduces the risk of fibrosis progression among non-cirrhotic adults with primary sclerosing cholangitis (PSC).

Trial with
Gilead Sciences
Ages
18 years - 75 years
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Suzie Christopher

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Marina Silveira, MD
Associate Professor of Medicine (Digestive Diseases)

Sub-Investigator

David N. Assis, MD

Last Updated
07/20/2023
Study HIC
#2000025197